We also analyzed the correlation between TET2 and PD-L1 by separating the CCLE breast cancer cell lines into three tumor subtypes and found that TET2 expression is negatively correlated with PD-L1 expression in luminal subtype (p = 0.0282) (Table S2). The gene discussed is TET2; the disease is neoplasm.